$ZIVO Balance Sheet | Understand Stock

$ZIVO

$3.60 -$0.35 (8.86%) Close

$ZIVO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2923 As of Dec 31, 2923	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020
CURRENT ASSETS:
Cash
Cash
Accounts receivable
Prepaid expenses
Total current assets
PROPERTY AND EQUIPMENT, NET
OTHER ASSETS:
Right of Use Asset, net
Deferred Offering Expenses
Deposits
Operating lease - right of use asset
Security deposit
Total other assets
TOTAL ASSETS
CURRENT LIABILITIES:
Accounts payable
Convertible Debentures Payable
Loans payable, related parties
Accounts payable - related party
Customer deposits
Current portion of long-term operating lease
Convertible debentures payable
Deferred R&D obligations - participation agreements
Deferred R&D obligations - participation agreements related parties
Loan Payable
Current portion of note payable
Convertible note - at fair value
Short term loan payable
Accrued interest
Accrued liabilities - employee bonus and salary
Total current liabilities
LONG TERM LIABILITIES:
Note -Payable - SBA Paycheck Protection Loan
Lease Liability, long term portion
Lease liabilities
Long-term note, net of current portion
Long-term note payable, net of current portion
Total long-term liabilities
TOTAL LIABILITIES
STOCKHOLDERS' EQUITY (DEFICIT):
Common stock, $0.001 par value, 25,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 3,832,327 and 3,621,335 issued and outstanding at September 30, 2025, and December 31, 2024, respectively
Additional paid-in capital
Accumulated deficit
Total stockholders' equity (deficit)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

Comments